Our research

Our current research includes

• Developing a preference-based, patient-reported outcome measure in Motor Neuron Disease

• Validating the EQ-HWB, a recently developed measure of quality of life and wellbeing for use in health and social care

• Valuing the SF-6Dv2, in many countries worldwide

• Assessing the psychometric properties including content validity of child and adolescent-specific preference-based measures: EQ-5D-Y, CHU9D

• Valuing the EQ-5D-5L and EQ-5D-Y in the UK

• Valuing health benefits for children and adolescents: research examining the impact of perspective and respondents’ priorities around adult and child health, and how to value health in adolescent samples

• Developing a preference-based measure for prolapse, incontinence and mesh complication surgery

• Validating the ReQOL-10, a recovery measure of quality of life

John Brazier and colleagues developed the SF-6D from the SF-36, a widely used PROM. The SF-6D allows utility values to be generated where the SF-36 has been used. The SF-6Dv2 has also been developed.

As a result of the SF-6D work, we have led the development of this methodology to develop condition-specific preference-based measures from existing PROMs in 

• asthma

• cancer

• diabetes

• dementia

• dermatitis

• epilepsy

• flushing

• incontinence

• mental health

• overactive bladder

• sexual quality of life

Members of SCHARR Outcomes also contributed to the recent valuation of the EQ-5D-5L and crosswalks from the EQ-5D-5L descriptive system to the EQ-5D-3L.

The COSMeQ project reviewed, developed and tested methods for deriving condition-specific preference-based measures (CSPBM) to generate QALYs from existing measures. This work contributed to the methodology in the assessment of labelling effects and how to value unidimensional measures.